HANQUYOU celebra su tercer aniversario con brillantes logros ...Middle East

PR Newswire - News
SHANGHAI, 28 de julio de 2023 /PRNewswire/ -- HANQUYOU (trastuzumab, nombre comercial en Europa: Zercepac®; nombres comerciales en Australia: Tuzucip® y Trastucip®), el primer biosimilar de trastuzumab desarrollado en China de forma independiente por Shanghai Henlius Biotech, Inc....

Hence then, the article about hanquyou celebra su tercer aniversario con brillantes logros was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( HANQUYOU celebra su tercer aniversario con brillantes logros )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News